S'abonner

The detection rate of granulomas differs between intestinal segments and lesions in Chinese patients with Crohn's disease - 02/02/23

Doi : 10.1016/j.clinre.2023.102076 
Lin-Teng Chen a, Jin-Yan Zhang a, b, Jian-Wei Zheng b, Juan Yu b, Yi Ding c, Wei-Lin Yang d, Hua Li a, b, , Wei-Feng Huang a, b,
a The School of Clinical Medicine, Fujian Medical University, Fuzhou, China 
b Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 
c Department of Pathology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 
d Endoscopy center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China 

Corresponding author at: The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.The School of Clinical Medicine, Fujian Medical UniversityFuzhouChina⁎⁎Corresponding author at: The School of Clinical Medicine, Fujian Medical University, Fuzhou, China.The School of Clinical Medicine, Fujian Medical UniversityFuzhouChina

Highlights

What is already known on this subject?
Non-caseating granulomas are a hallmark histologic finding for the diagnosis of Crohn's disease. But the detection rate of granulomas at endoscopy was low.
What are the new findings?
The detection rate of granulomas differs between intestinal segments and lesions in patients with Crohn's disease.
How might it impact on clinical practice in the foreseeable future?
The research may help to improve the detection rate of granulomas in clinical practice.

Le texte complet de cet article est disponible en PDF.

Abstract

Background

Crohn's disease (CD) is characterized by non-caseating intestinal granulomas. However, the reported detection rate of granulomas on endoscopy is low. This study aimed to analyze the differences in the detection rate of granulomas in different intestinal segments and lesions in Chinese patients with CD to improve the detection rate of granulomas in clinical practice.

Patients and methods

113 patients with CD were analyzed retrospectively. Patients were divided into two groups: those with (n = 51) and without granulomas (n = 62) on endoscopic biopsies. Clinical information was collected from the medical records, including age; erythrocyte sedimentation rate (ESR); C-reactive protein (CRP), albumin, and hemoglobin (Hb) levels; platelet count; disease course; sex; smoking history; related operation history; Montreal classification; and lesion location, size, and shape.

Results

The detection rates of granulomas in different lesion shapes were significantly different (P < 0.001), with those of longitudinal ulcers and circular ulcers being higher than those of erosion and irregular ulcers. We also found that the detection rates of granulomas in ascending colon and sigmoid colon were relatively higher than other segments of the intestine, however, the difference was not statistically significant (P = 0.716). Additionally, age, sex, smoking history, Montreal classification, related surgical history, disease course, and serum biochemical indicators (ESR; platelet count; and CRP, albumin, and Hb levels) were not significantly different between the two groups.

Conclusions

The detection rate of granulomas in patients with CD is related to the morphology of the intestinal lesions. Meanwhile, lesion location may be correlated with the detection rate of granulomas.

Le texte complet de cet article est disponible en PDF.

Keywords : Granuloma, Detection rate, Crohn's disease, Endoscopic biopsy, Ulcer


Plan


© 2023  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 47 - N° 2

Article 102076- février 2023 Retour au numéro
Article précédent Article précédent
  • Clinical application study on miR-98–5p as a prognostic biomarker in hepatocellular carcinoma
  • Peng-tian Ji, Xiao-yan Wang
| Article suivant Article suivant
  • Drug-induced hepatitis (DIH) after SARS-CoV-2 vaccination
  • Ali Asgarzdeh, Shahram Habibzadeh, Vahid Asghariazar, Elham Safarzadeh

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.